Science, July 2018: of 107 FDA advisers who voted on drugs, 40 later got over $10,000 from the makers or competitors, 26 over $100,000 and six over $1 million. FDA, advisers and companies gave responses in the article.
Of 107 physician advisers who voted on the committees Science examined, 40 over a nearly 4-year period received more than $10,000 in post hoc earnings or research support from the makers of drugs that the panels voted to approve, or from competing firms; 26 of those gained more than $100,000; and six more than $1 million.
Science, July 2018: of 107 FDA advisers who voted on drugs, 40 later got over $10,000 from the makers or competitors, 26 over $100,000 and six over $1 million. FDA, advisers and companies gave responses in the article.